These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 26562694

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK.
    Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
    Camenga DR, Dunne EF, Desai MM, Gee J, Markowitz LE, Desiliva A, Klein NP.
    Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
    [Abstract] [Full Text] [Related]

  • 5. Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents.
    Perkins RB, Lin M, Wallington SF, Hanchate A.
    Sex Transm Dis; 2017 Jun; 44(6):365-370. PubMed ID: 28499288
    [Abstract] [Full Text] [Related]

  • 6. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J, Perkins N.
    N Z Med J; 2011 Jul 29; 124(1339):51-8. PubMed ID: 21952330
    [Abstract] [Full Text] [Related]

  • 7. Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007-2018).
    Cocchio S, Prandi GM, Furlan P, Bertoncello C, Fonzo M, Saia M, Baldovin T, Baldo V.
    BMC Infect Dis; 2020 Nov 18; 20(1):857. PubMed ID: 33208109
    [Abstract] [Full Text] [Related]

  • 8. Promising control of genital warts: but is elimination possible?
    Lacey CJ, Garnett GP.
    Lancet Infect Dis; 2011 Jan 18; 11(1):4-6. PubMed ID: 21183139
    [No Abstract] [Full Text] [Related]

  • 9. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
    Lurie S, Mizrachi Y, Chodick G, Katz R, Schejter E.
    Gynecol Oncol; 2017 Aug 18; 146(2):299-304. PubMed ID: 28602548
    [Abstract] [Full Text] [Related]

  • 10. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ.
    BMJ; 2013 Apr 18; 346():f2032. PubMed ID: 23599298
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.
    Thöne K, Horn J, Mikolajczyk R.
    BMC Infect Dis; 2017 Aug 14; 17(1):564. PubMed ID: 28806926
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
    Ali H, McManus H, O'Connor CC, Callander D, Kong M, Graham S, Saulo D, Fairley CK, Regan DG, Grulich A, Low N, Guy RJ, Donovan B.
    Med J Aust; 2017 Mar 20; 206(5):204-209. PubMed ID: 28301790
    [Abstract] [Full Text] [Related]

  • 15. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.
    Haupt RM, Sings HL.
    J Adolesc Health; 2011 Nov 20; 49(5):467-75. PubMed ID: 22018560
    [Abstract] [Full Text] [Related]

  • 16. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM, Heywood A, Heley S.
    Sex Health; 2009 Sep 20; 6(3):178-84. PubMed ID: 19653953
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males.
    Korostil IA, Ali H, Guy RJ, Donovan B, Law MG, Regan DG.
    Sex Transm Dis; 2013 Nov 20; 40(11):833-5. PubMed ID: 24113401
    [Abstract] [Full Text] [Related]

  • 19. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
    Canvin M, Sinka K, Hughes G, Mesher D.
    Sex Transm Infect; 2017 Mar 20; 93(2):125-128. PubMed ID: 27365492
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E, López-Lacort M, Navarro-Illana P, Vilata JJ, Diez-Domingo J.
    Vaccine; 2017 Jun 05; 35(25):3342-3346. PubMed ID: 28499554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.